Loading…
The DiaTrust Covid-19 IgG/IgM Rapid Test, jointly developed by Celltrion and Humasis, received FDA emergency use authorization. Celltrion USA also signed a $214.5 million supply contract with Prime Healthcare Distributors.
Celltrion USA signed a contract with Prime Healthcare Distributors to supply its Sampinute COVID-19 rapid antigen test kits across the United States. The deal is valued at 210 billion won (approximately $1.9 billion) and grants Prime Healthcare exclusive distribution rights.